Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;17(Suppl):S45-51.
doi: 10.4103/0973-1075.76243.

Gynaecological malignancies from palliative care perspective

Kamlesh Mishra  1
Affiliations

Gynaecological malignancies from palliative care perspective

Kamlesh Mishra. Indian J Palliat Care. 2011 Jan.

Abstract

Of the approximately 80,000 new cases of all cancers detected every year in India, 10-15% are gynecological malignancies. As per population-based registries under the National Cancer Registry Program, the leading sites of cancer among women are the cervix uteri, breast, and oral cavity. About 50-60% of all cancers among women in India are mainly of the following four organs: cervix uteri, breast, corpus uteri, and ovaries. Over 70% of these women report for diagnostic and treatment services at an advanced stage of disease, resulting in poor survival and high mortality rates. Among all gynecological cancers, ovarian cancer is the deadliest one and, in 2/3(rd) of the cases, is detected in an advanced stage. But, in India and in other developing countries, due to inadequate screening facilities for the preventable cancer cervix, this kills more women than any other cancer in females. Gynecology Oncologist as a sub-specialist has an immensely important role in curtailing the menace of gynecological malignancies by providing comprehensive preventive, curative, palliative and follow-up services, with the aim of assuring a good quality of life to women as a cornerstone of cancer management.

Keywords: Gynecological malignancies; Palliative care; Symptomatic care.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Consolidated report of hospital based cancer registries 2001-3, national cancer registry program. New Delhi: Indian Council of Medical Research; 2007.
    1. Muruganandham K, Kapoor R. Malignant ureteral obstruction: Whether decompression really improves patient outcomes and quality of life? Indian J Urol. 2008;24:127–8. - PMC - PubMed
    1. Mishra K, Desai A, Patel S, Mankad M, Dave K. Role of percutaneous nephrostomy in advanced cervical carcinoma with obstructive uropathy: A case series. Indian J Palliat Care. 2009;15:37–40. - PMC - PubMed
    1. Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol. 2003;43:148–51. - PubMed
    1. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. Barakat; The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103:714–8. - PubMed